Wednesday, March 11, 2009

Synerx Pharma Announces First Approval of Generic Equivalent to Ovide

Synerx Pharma, LLC announces the approval of its Abbreviated New Drug Application for Malathion Lotion, 0.5%. The product represents the first approval of a generic equivalent to Ovide®.

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)